Simone Hausmann

Instructor at MD Anderson Cancer Center - Pancreatic and Lung Cancer. Interested in drug resistance mechanisms

[Sebastian S. Cocioba🪄🌷 @ATinyGreenCell]

I got hit by some rather sudden and extreme financial hardship so if anyone is in need of remote wetlab contract research, strictly BSL1, do let me know. Currently scrambling for gigs.

Plant, Bacterial, Archaeal Bioeng
Custom Lab Hardware
Turn Key Genetic Design

Please RT 💚

[Shiv K Singh & Lab @ShivKSingh6]

📢 Excited to share our study in @NatureComms, previously available on bioRxiv by Klein et al.
👉 https://t.co/tqT4g9d39B

[CrozrX @CrozrX]

Increased KRAS mutant allele dosage is an important negative prognostic feature that will need to be integrated into clinical practice as we move into the era of 🎯 RAS-directed therapeutics for PDAC.
🔸️
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
🔸️
https://t.co/6tFBTKV2yl

[Justin Manning ⓥ @justinmanningv]

My mom is dying from pancreatic cancer.

She’s only 65.

She’s my best friend outside my wife and daughter.

I’m in the hospital with her right now (she’s sleeping) as I write this.

She’s been in the hospital for almost the last two months.

[Simone Hausmann @Simone_Hausmann]

@MilliporeSigma Something sweet after the hurricane would be nice #SigmaAldrichChocolate @NatashaMFlores

[Simone Hausmann @Simone_Hausmann]

@jdpereira Here in Houston it’s not very pleasant to walk. But when I still lived in my home country I was also walking a lot every day. Miss it so much!

[Simone Hausmann @Simone_Hausmann]

@MartinJastroch Congratulations 🎉🍾

[Algül Lab @AlgulLab]

Algül Lab is hiring a new postdoctoral researcher! If you are excited to work in the pancreatic cancer field under the funded BMBF consortium, we are looking forward to seeing your applications! Please spread the word!😊#pancreaticcancer #postdoc
https://t.co/CgUqDpMDRv

[Kıvanç Görgülü @kivancgorgulu]

Do not miss this great opportunity in our lab🤗

[Simone Hausmann @Simone_Hausmann]

The MazurLab @MDAndersonNews was walking at the #PanCANPurpleStride #PurpleStrideHouston today to raise awareness for this devastating disease and show support for pancreatic cancer survivors @PanCAN @PancanHouston

[Simone Hausmann @Simone_Hausmann]

@LauraRyderT @GSnieckute @AnnaCVind @ScienceMagazine Congratulations!

[Simone Hausmann @Simone_Hausmann]

@DavidCWhitcomb @PittGILiverNutr @PanCAN @NatPancFdn @acg mammary gland

[David C Whitcomb MD PhD @DavidCWhitcomb]

#PancreaticCancer & #ArtificialInteligence.
Cao https://t.co/xAB6q2Vb24. published a paper in Nature (20Nov23 online) claiming an (AUC) of 0.986–0.996 for detection of pancreatic lesions including adenocarcinoma (#PDAC) using non-contrast CT.
BUT, there is a BIG problem. (flow me for the answers)
The training and testing was in cohorts with very high rates of known pancreatic cancers and known lesions. In "real" real world testing of the general population, where the incidence of occult pancreatic cancers is <0.001, the false positive rate would be huge compared to true positive (see PMID: 14731128 as an example).
The key is to screen for occult PDAC in patients with a high risk for pancreatic cancer (PMID: 35704792) and with early signs and symptoms (PMID: 35065983).
The new PANDA tool will fail as a CT screening tool for detection of occult PDAC in a general population. The utility will likely be as an aid to radiologist that are not experts at reading a non-contrast CT of the pancreas. Period.
The solution to the stratification problem of defining high, and very high risk sub-populations will be discussed later. Stay tuned to @davidcwhitcomb .
https://t.co/Ons8LdafCi
Note: PMID is the PubMed number on the https://t.co/CbxJgUExlK web site.
@PanCAN @NatPancFdn @UPMC @lustgartenfdn @PancPathologist @Aiims1742 @ArielMedicine #pancreatitis #deeplearning #DigitalHealth #PrecisionMedicine @AmCollegeGastro @PittGILiverNutr @GIPapachristou

[KenOliveLab @KenOliveLab]

We are excited to share our preprint on the effects of RAS-GTP inhibition in preclinical models of PDAC, using RMC-7977, a potent inhibitor of GTP-bound RAS proteins. This preclinical agent is related to RMC-6236, currently in clinical trials. https://t.co/u256sIWNwl

[Dr. Dr. Helene Andrews-Polymenis, @HPolymenis]

A primer on genetic testing in pancreas cancer. Insist on it- it could save your life! It’s saving mine. Please retweet! ⁦@letswinpc⁩ ⁦@PanCAN⁩ ⁦@Run4Purple⁩ ⁦@DinoVPurple⁩ ⁦@MPishvaian⁩

[Houston - Pancreatic Cancer Action Network @PanCANHouston]

November is Pancreatic Cancer Awareness Month! 🎗📆💜 Head to https://t.co/yhV9zv04fo to learn how you can get involved and raise awareness in our community this month. #PanCANAwareness

[Simone Hausmann @Simone_Hausmann]

@ACKoongMDPhD @wenjiang_nano @Dr_Di_Zhao @MDAndersonNews Congratulations Pawel Mazur @Mazurlab

[Max Planck Institute of Biochemistry (MPIB) @MPI_Biochem]

You hold a PhD degree in the area of #lifesciences and have also gained some experience in either education, research or research administration?

We have a #job for you!
❕ Apply until July 24
❕ https://t.co/kWX1zurkiO

#hiring #scienceeducation #jobalert #joboffer @IMPRS_ML

[The Conrad Lab @Conrad_Lab]

We are excited to share our #mattersarising piece out today in @Nature ! Let us walk you through the main take-homes, which we believe are of utmost importance to the entire #ferroptosis field! 1/n

https://t.co/cl8TSGEU8R

[Martin Klingenspor @MartinKlingens4]

Exciting new opportunities @TUM in Munich:
Two open professorships for organoid technologies 🙂
https://t.co/m0CB9yETny